An in-vitro study of the antimicrobial susceptibilities of Yersinia enterocolitica and the definition of a database

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 1, 1999, Pages 37-45

  Stock, Ingo ^a   Wiedemann, Bernd ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; APRAMYCIN; AZLOCILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFAZOLIN; CLAVULANIC ACID; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; KANAMYCIN; LIVIDOMYCIN; MEZLOCILLIN; MINOCYCLINE; NEOMYCIN; NETILMICIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; RIBOSTAMYCIN; SPECTINOMYCIN; STREPTOMYCIN; SULBACTAM; TAZOBACTAM; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; DATA BASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE; YERSINIA ENTEROCOLITICA;

ANTI-BACTERIAL AGENTS; DATABASES, FACTUAL; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY; YERSINIA ENTEROCOLITICA;

EID: 0032949945     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.1.37     Document Type: Article

References (21)

1. McIver, M. A. & Pike, R. M. (1934). Chronic glanders-like infection of the face caused by an organism resembling Flavobacterium pseudomallei Whitmore. In Clinical Miscellany, Vol. 1, pp. 16-21. Mary Imogene Basset Hospital, Cooperstown, NY.
2. Bottone, E. J. (1997). Yersinia enterocolitica: The charisma continues. Clinical Microbiology Reviews 10, 257-76.
3. Ibrahim, A., Goebel, G. M., Liesack, W., Griffiths, M. & Stackebrandt, E. (1993). The phylogeny of the genus Yersinia based on 16S rRNA sequences. FEMS Microbiology Letters 114, 173-7.
4. Ibrahim, A. (1995). Genetic diversity among Yersinia enterocolitica strains as revealed by sequence analysis of the 16S rRNA gene. Contributions to Microbiology and Immunology 13, 277-80.
5. Wauters, G., Kandolo, K. & Janssens, M. (1987). Revised biogrouping scheme of Yersinia enterocolitica. Contributions to Microbiology and Immunology 9, 14-21.
6. Wauters, G., Janssens, M., Steigerwalt, A. G. & Brenner, D. J. (1988). Yersinia mollaretii sp. nov. and Yersinia bercovieri sp. nov., formerly called Yersinia enterocolitica biogroups 3A and 3B. International Journal of Systematic Bacteriology 38, 424-9.
7. Stolk-Engelaar, V. M. M., Meis, J. F. G. M., Mulder, J. A., Loeffen, F. L. A. & Hoogkamp-Korstanje, J. A. A. (1995). In-vitro antimicrobial susceptibility of Yersinia enterocolitica isolates from stools of patients in the Netherlands from 1982-1991. Journal of Antimicrobial Chemotherapy 36, 839-43.
8. Preston, M. A., Brown, S., Borczyk, A. A., Riley, G. & Krishnan C. (1994). Antimicrobial susceptibility of pathogenic Yersinia enteroco litica isolated in Canada from 1972 to 1990. Antimicrobial Agents and Chemotherapy 38, 2121-4.
9. Ahmedy, A., Vidon, D. J., Delmas, C. L. & Lett, M.-C. (1985). Antimicrobial susceptibilities of food-isolated strains of Yersinia enterocolitica, Y. intermedia, Y. frederiksenii, and Y. kristensenii. Antimicrobial Agents and Chemotherapy 28, 351-3.
10. Toma, S. & Lafleur, L. (1974). Survey of the incidence of Yersinia enterocolitica infection in Canada. Applied Microbiology 28, 469-73.
11. Pham, J. N., Bell, S. M. & Lanzarone, J. Y. M. (1991). Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica. Journal of Antimicrobial Chemotherapy 28, 13-8.
12. Kwaga, J. & Iversen, J. O. (1990). In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products. Antimicrobial Agents and Chemotherapy 34, 2423-5.
13. Stock, I. & Wiedemann, B. (1997). Natürliche Antibiotika-Empfindlichkeit von Proteus-Spezies im Proteus-vulgaris-Komplex. Chemotherapie Journal 6, 76-84.
14. Stock, I. & Wiedemann, B. (1998). Identification and natural antibiotic susceptibility of Morganella morganii. Diagnostic Microbiology and Infectious Disease 30, 153-65.
15. Stock, I. & Wiedemann, B. (1998). Natural antibiotic susceptibility of Providencia stuartii, Providencia rettgeri, Providencia alcalifaciens and Providencia rustigianii strains. Journal of Medical Microbiology 47, 629-42.
16. Cornelis, G. & Abraham, E. P. (1975). β-Lactamases from Yersinia enterocolitica. Journal of General Microbiology 87, 273-84.
17. Seoane, A. & Garcia Lobo, J. M. (1991). Nucleotide sequence of a new class A β-lactamase gene from the chromosome of Yersinia enterocolitica : implication for the evolution of class A β-lactamases. Molecular and General Genetics 228, 215-20.
18. Seoane, A., Francia, M. V. & Lobo, J. M. (1992). Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica. Antimicrobial Agents and Chemotherapy 36, 1049-52.
19. Matthew, M., Cornelis, G. & Wauters, G. (1977). Correlation of serological and biochemical groupings of Yersinia enterocolitica with the β-lactamases of the strains. Journal of General Microbiology 102, 55-9.
20. Pham, J. N., Bell, S. M. & Lanzarone, J. Y. M. (1991). A study of the β-lactamases of 100 clinical isolates of Yersinia enterocolitica. Journal of Antimicrobial Chemotherapy 28, 19-24.
21. Pham, J. N., Bell, S. M., Hardy, M. J., Martin, L., Guiyoule, A. & Carniel, E. (1995). Susceptibility to β-lactam agents of Yersinia enterocolitica biotype 4, serotype O3 isolated in various parts of the world. Journal of Medical Microbiology 43, 9-13.